Wennström, Malin https://orcid.org/0000-0002-9957-1801
Janelidze, Shorena
Nilsson, K. Peter R.
,
Serrano, Geidy E.
Beach, Thomas G.
Dage, Jeffrey L.
Hansson, Oskar
Funding for this research was provided by:
Vetenskapsrådet (2016-00906)
Vetenskapsrådet (2018-02564)
Marianne and Marcus Wallenberg Foundation (2015.0125)
Multidisciplinary Research in Parkinson’s disease
Swedish Alzheimer Foundation (AF-939932)
Hjärnfonden (FO2021-0293)
The Parkinson foundation of Sweden (1280/20)
the Skåne University Hospital Foundation (2020-O000028)
Regionalt Forskningsstöd (2020-0314)
the Swedish federal government under the ALF agreement (2018-Projekt0279)
the National Institute of Neurological Disorders and Stroke (U24 NS072026)
National Institute on Aging (P30 AG19610)
Arizona Department of Health Services (211002)
Arizona Biomedical Research Commission (4001)
Arizona Biomedical Research Commission (0011)
Arizona Biomedical Research Commission (05-901)
Arizona Biomedical Research Commission (1001)
Michael J. Fox Foundation for Parkinson's Research
LRAP
Lund University
Article History
Received: 22 December 2021
Accepted: 22 December 2021
First Online: 6 January 2022
Declarations
:
: The procedures of brain tissue and plasma collection and forms were approved, for Cohort 1, by the medical ethics committee of VU medical center in Amsterdam (the Netherlands), for Cohort 2 by the Western Institutional Review Board of Puyallup, Washington (USA), and for this study by the regional ethical review board in Lund.
: Not applicable.
: OH has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from Roche, Genentech, Siemens, Biogen, Alzpath, and Cerveau.